GIUSEPPE DI BELLA > NEWS > null > null > I Retinoidi nelle malattie linfoproliferative

 
I Retinoidi nelle malattie linfoproliferative di S.I.B.O.R. - M.D.B.
 
 
Data: 14/07/2006
Tipologia: MDB - Documentazione
Lingua: Italiano
Anno: 2006
 
 
Descrizione:
PER LEGGERE E SCARICARE IL CAPITOLO SUI RETINOIDI, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 69 pagine in formato PDF e pesa 243 kb.



BIBLIOGRAFIA






Adachi, Y., F. Itoh, et al. (2001). "Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer." Tumour Biol 22(4): 247-53.






Antony, P., L. Freysz, et al. (2001). "Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells." Neurochem Res 26(1): 83-8.






Arany, I., I. A. Ember, et al. (2003). "All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells." Anticancer Res 23(1A): 471-3.






Arany, I., W. E. Whitehead, et al. (2003). "Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells." Anticancer Res 23(1A): 495-7.






Avvisati, G. and M. S. Tallman (2003). "All-trans retinoic acid in acute promyelocytic leukaemia." Best Pract Res Clin Haematol 16(3): 419-32.






Baranowitz, S. A. (1994). "Treatment of cutaneous T-cell lymphoma with beta carotene." N Engl J Med 330(25): 1830.






Baroni, A., I. Paoletti, et al. (2003). "Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis." Br J Dermatol 148(3): 424-33.






Basu, M., A. Banerjee, et al. (2000). "Beta-carotene prolongs survival, decreases lipid peroxidation and enhances glutathione status in transplantable murine lymphoma." Phytomedicine 7(2): 151-9.






Bertram, J. S. and A. L. Vine (2005). "Cancer prevention by retinoids and carotenoids: Independent action on a common target." Biochim Biophys Acta 1740(2): 170-8.






Bonnefoix, T., R. Gressin, et al. (1997). "Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells induced by various cytokines and all-trans-retinoic-acid." Leuk Lymphoma 25(1-2): 169-78.






Burg, G. and R. Dummer (2000). "Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL)." Clin Lymphoma 1 Suppl 1: S41-4.






Carystinos, G. D., M. A. Alaoui-Jamali, et al. (2001). "Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells." Cancer Chemother Pharmacol 47(2): 126-32.






Chen, G. S., Y. F. Chang, et al. (1998). "Response of Epstein-Barr virus-associated Ki-1+ anaplastic large cell lymphoma to 13-cis retinoic acid and interferon alpha." J Formos Med Assoc 97(6): 420-4.






Cheng, A. L., I. J. Su, et al. (1994). "Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study." J Clin Oncol 12(6): 1185-92.






Chou, H. K., S. L. Chen, et al. (2000). "Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells." Biochem J 348 Pt 2: 473-9.






Chou, W. C., I. J. Su, et al. (1996). "Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid." Cancer 78(8): 1805-12.






Chow, J. M., A. L. Cheng, et al. (1991). "13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma." Cancer 67(10): 2490-4.






Dillehay, D. L., Y. F. Shealy, et al. (1989). "Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids." Cancer Res 49(1): 44-50.






Findley, H. W., Jr., C. P. Steuber, et al. (1984). "Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study." Exp Hematol 12(10): 768-73.






Ghosh, B., A. Mandal, et al. (1995). "Physiological potential of beta-carotene in prolonging the survival of the host bearing transplantable murine lymphoma." Planta Med 61(4): 317-20.






Ghosh, B., S. Sardar, et al. (1995). "Role of beta-carotene on the changes in activity patterns and levels of biotransforming enzymes in transplantable murine lymphoma." Cancer Lett 90(2): 191-7.






Guidoboni, M., P. Zancai, et al. (2005). "Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma." Cancer Res 65(2): 587-95.






Heald, P. (2000). "The treatment of cutaneous T-cell lymphoma with a novel retinoid." Clin Lymphoma 1 Suppl 1: S45-9.






Huang, C. L., Z. Z. Lin, et al. (2002). "Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma." Leuk Lymphoma 43(7): 1415-20.






Igarashi, T., M. Abe, et al. (2001). "Retinoic acids repress the expression of ETS-1 in endothelial cells." Tohoku J Exp Med 194(1): 35-43.






Kelloff, G. J., C. W. Boone, et al. (1996). "New agents for cancer chemoprevention." J Cell Biochem Suppl 26: 1-28.






Kempf, W., N. Kettelhack, et al. (2003). "Topical and systemic retinoid therapy for cutaneous T-cell lymphoma." Hematol Oncol Clin North Am 17(6): 1405-19.






Kessler, J. F., S. E. Jones, et al. (1987). "Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)." Arch Dermatol 123(2): 201-4.






Kessler, J. F., F. L. Meyskens, Jr., et al. (1983). "Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid." Lancet 1(8338): 1345-7.






Kim, S. N., S. G. Kim, et al. (2000). "Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells." J Cell Physiol 182(3): 421-8.






Kini, A. R., L. A. Peterson, et al. (2001). "Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid." Blood 97(12): 3919-24.






Knobler, R. M., F. Trautinger, et al. (1991). "Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids." J Am Acad Dermatol 24(2 Pt 1): 247-52.






Lee, M. O., S. Y. Han, et al. (2000). "Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta." Biochem Pharmacol 59(5): 485-96.






Lippman, S. M. and F. L. Meyskens, Jr. (1988). "Vitamin A derivatives in the prevention and treatment of human cancer." J Am Coll Nutr 7(4): 269-84.






Majewski, S., A. Szmurlo, et al. (1994). "Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines." Int J Cancer 57(1): 81-5.






Mettlin, C. (1984). "Epidemiologic studies on vitamin A and cancer." Adv Nutr Res 6: 47-65.






Neely, S. M., M. Mehlmauer, et al. (1987). "The effect of isotretinoin in six patients with cutaneous T-cell lymphoma." Arch Intern Med 147(3): 529-31.






Niitsu, N., M. Higashihara, et al. (2002). "Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma." Leuk Res 26(8): 745-55.






Oikawa, T., K. Hirotani, et al. (1989). "A highly potent antiangiogenic activity of retinoids." Cancer Lett 48(2): 157-62.






Okuno, M., S. Kojima, et al. (2004). "Retinoids in cancer chemoprevention." Curr Cancer Drug Targets 4(3): 285-98.






Onogi, N., M. Okuno, et al. (1998). "Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid." Nutr Cancer 32(1): 20-4.






Pal, S., M. L. Iruela-Arispe, et al. (2000). "Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade." Microvasc Res 60(2): 112-20.






Piedrafita, F. J. and M. Pfahl (1997). "Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation." Mol Cell Biol 17(11): 6348-58.






Pitha-Rowe, I., W. J. Petty, et al. (2003). "Retinoid target genes in acute promyelocytic leukemia." Leukemia 17(9): 1723-30.






Przybyszewska, M. (1985). "A protective role of 13-cis retinoic acid in thymic lymphoma induction." Arch Immunol Ther Exp (Warsz) 33(6): 811-5.






Przybyszewska, M., B. Szaniawska, et al. (1986). "Effect of 13-cis-retinoic acid on the spontaneous thymic lymphoma development in AKR mice." Neoplasma 33(3): 341-4.






Querfeld, C., S. T. Rosen, et al. (2004). "Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma." J Am Acad Dermatol 51(1): 25-32.






Riondel, J., H. K. Wong, et al. (2002). "The effect of a water-dispersible beta-carotene formulation on the prevention of age-related lymphoid neoplasms in mice." Anticancer Res 22(2A): 883-8.






Sanz, M. A., G. Martin, et al. (2003). "Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia." Best Pract Res Clin Haematol 16(3): 433-51.






Serri, F., C. De Simone, et al. (1990). "Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas." Curr Probl Dermatol 19: 252-7.






Soprano, D. R., P. Qin, et al. (2004). "Retinoic acid receptors and cancers." Annu Rev Nutr 24: 201-21.






Su, I. J., A. L. Cheng, et al. (1993). "Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes." Br J Haematol 85(4): 826-8.






Tallman, M. S. (2004). "Acute promyelocytic leukemia as a paradigm for targeted therapy." Semin Hematol 41(2 Suppl 4): 27-32.






Thomsen, K. (1995). "Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatment." Lancet 345(8964): 1583.






Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.






Turley, J. M., S. Funakoshi, et al. (1995). "Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta." Cell Growth Differ 6(6): 655-63.






Voigt, A., P. Hartmann, et al. (2000). "Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid." Cell Adhes Commun 7(5): 423-40.






Wang, K. C., A. L. Cheng, et al. (2000). "Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions." Exp Hematol 28(12): 1441-50.






Warrell, R. P., Jr., C. J. Coonley, et al. (1983). "Isotretinoin in cutaneous T-cell lymphoma." Lancet 2(8350): 629.






Wu, Q., Z. Chen, et al. (2001). "Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression." Chin Med J (Engl) 114(9): 958-61.






Younes, A., M. Cristofanilli, et al. (2000). "Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma." Leuk Lymphoma 40(1-2): 79-85.






Zhang, C. and M. Duvic (2003). "Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma." Dermatol Ther 16(4): 322-30.

 
 
 

PER LEGGERE E SCARICARE IL CAPITOLO SUI RETINOIDI, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 69 pagine in formato PDF e pesa 243 kb.



BIBLIOGRAFIA






Adachi, Y., F. Itoh, et al. (2001). "Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer." Tumour Biol 22(4): 247-53.






Antony, P., L. Freysz, et al. (2001). "Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells." Neurochem Res 26(1): 83-8.






Arany, I., I. A. Ember, et al. (2003). "All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells." Anticancer Res 23(1A): 471-3.






Arany, I., W. E. Whitehead, et al. (2003). "Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells." Anticancer Res 23(1A): 495-7.






Avvisati, G. and M. S. Tallman (2003). "All-trans retinoic acid in acute promyelocytic leukaemia." Best Pract Res Clin Haematol 16(3): 419-32.






Baranowitz, S. A. (1994). "Treatment of cutaneous T-cell lymphoma with beta carotene." N Engl J Med 330(25): 1830.






Baroni, A., I. Paoletti, et al. (2003). "Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis." Br J Dermatol 148(3): 424-33.






Basu, M., A. Banerjee, et al. (2000). "Beta-carotene prolongs survival, decreases lipid peroxidation and enhances glutathione status in transplantable murine lymphoma." Phytomedicine 7(2): 151-9.






Bertram, J. S. and A. L. Vine (2005). "Cancer prevention by retinoids and carotenoids: Independent action on a common target." Biochim Biophys Acta 1740(2): 170-8.






Bonnefoix, T., R. Gressin, et al. (1997). "Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells induced by various cytokines and all-trans-retinoic-acid." Leuk Lymphoma 25(1-2): 169-78.






Burg, G. and R. Dummer (2000). "Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL)." Clin Lymphoma 1 Suppl 1: S41-4.






Carystinos, G. D., M. A. Alaoui-Jamali, et al. (2001). "Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells." Cancer Chemother Pharmacol 47(2): 126-32.






Chen, G. S., Y. F. Chang, et al. (1998). "Response of Epstein-Barr virus-associated Ki-1+ anaplastic large cell lymphoma to 13-cis retinoic acid and interferon alpha." J Formos Med Assoc 97(6): 420-4.






Cheng, A. L., I. J. Su, et al. (1994). "Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study." J Clin Oncol 12(6): 1185-92.






Chou, H. K., S. L. Chen, et al. (2000). "Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells." Biochem J 348 Pt 2: 473-9.






Chou, W. C., I. J. Su, et al. (1996). "Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid." Cancer 78(8): 1805-12.






Chow, J. M., A. L. Cheng, et al. (1991). "13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma." Cancer 67(10): 2490-4.






Dillehay, D. L., Y. F. Shealy, et al. (1989). "Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids." Cancer Res 49(1): 44-50.






Findley, H. W., Jr., C. P. Steuber, et al. (1984). "Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study." Exp Hematol 12(10): 768-73.






Ghosh, B., A. Mandal, et al. (1995). "Physiological potential of beta-carotene in prolonging the survival of the host bearing transplantable murine lymphoma." Planta Med 61(4): 317-20.






Ghosh, B., S. Sardar, et al. (1995). "Role of beta-carotene on the changes in activity patterns and levels of biotransforming enzymes in transplantable murine lymphoma." Cancer Lett 90(2): 191-7.






Guidoboni, M., P. Zancai, et al. (2005). "Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma." Cancer Res 65(2): 587-95.






Heald, P. (2000). "The treatment of cutaneous T-cell lymphoma with a novel retinoid." Clin Lymphoma 1 Suppl 1: S45-9.






Huang, C. L., Z. Z. Lin, et al. (2002). "Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma." Leuk Lymphoma 43(7): 1415-20.






Igarashi, T., M. Abe, et al. (2001). "Retinoic acids repress the expression of ETS-1 in endothelial cells." Tohoku J Exp Med 194(1): 35-43.






Kelloff, G. J., C. W. Boone, et al. (1996). "New agents for cancer chemoprevention." J Cell Biochem Suppl 26: 1-28.






Kempf, W., N. Kettelhack, et al. (2003). "Topical and systemic retinoid therapy for cutaneous T-cell lymphoma." Hematol Oncol Clin North Am 17(6): 1405-19.






Kessler, J. F., S. E. Jones, et al. (1987). "Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)." Arch Dermatol 123(2): 201-4.






Kessler, J. F., F. L. Meyskens, Jr., et al. (1983). "Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid." Lancet 1(8338): 1345-7.






Kim, S. N., S. G. Kim, et al. (2000). "Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells." J Cell Physiol 182(3): 421-8.






Kini, A. R., L. A. Peterson, et al. (2001). "Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid." Blood 97(12): 3919-24.






Knobler, R. M., F. Trautinger, et al. (1991). "Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids." J Am Acad Dermatol 24(2 Pt 1): 247-52.






Lee, M. O., S. Y. Han, et al. (2000). "Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta." Biochem Pharmacol 59(5): 485-96.






Lippman, S. M. and F. L. Meyskens, Jr. (1988). "Vitamin A derivatives in the prevention and treatment of human cancer." J Am Coll Nutr 7(4): 269-84.






Majewski, S., A. Szmurlo, et al. (1994). "Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines." Int J Cancer 57(1): 81-5.






Mettlin, C. (1984). "Epidemiologic studies on vitamin A and cancer." Adv Nutr Res 6: 47-65.






Neely, S. M., M. Mehlmauer, et al. (1987). "The effect of isotretinoin in six patients with cutaneous T-cell lymphoma." Arch Intern Med 147(3): 529-31.






Niitsu, N., M. Higashihara, et al. (2002). "Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma." Leuk Res 26(8): 745-55.






Oikawa, T., K. Hirotani, et al. (1989). "A highly potent antiangiogenic activity of retinoids." Cancer Lett 48(2): 157-62.






Okuno, M., S. Kojima, et al. (2004). "Retinoids in cancer chemoprevention." Curr Cancer Drug Targets 4(3): 285-98.






Onogi, N., M. Okuno, et al. (1998). "Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid." Nutr Cancer 32(1): 20-4.






Pal, S., M. L. Iruela-Arispe, et al. (2000). "Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade." Microvasc Res 60(2): 112-20.






Piedrafita, F. J. and M. Pfahl (1997). "Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation." Mol Cell Biol 17(11): 6348-58.






Pitha-Rowe, I., W. J. Petty, et al. (2003). "Retinoid target genes in acute promyelocytic leukemia." Leukemia 17(9): 1723-30.






Przybyszewska, M. (1985). "A protective role of 13-cis retinoic acid in thymic lymphoma induction." Arch Immunol Ther Exp (Warsz) 33(6): 811-5.






Przybyszewska, M., B. Szaniawska, et al. (1986). "Effect of 13-cis-retinoic acid on the spontaneous thymic lymphoma development in AKR mice." Neoplasma 33(3): 341-4.






Querfeld, C., S. T. Rosen, et al. (2004). "Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma." J Am Acad Dermatol 51(1): 25-32.






Riondel, J., H. K. Wong, et al. (2002). "The effect of a water-dispersible beta-carotene formulation on the prevention of age-related lymphoid neoplasms in mice." Anticancer Res 22(2A): 883-8.






Sanz, M. A., G. Martin, et al. (2003). "Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia." Best Pract Res Clin Haematol 16(3): 433-51.






Serri, F., C. De Simone, et al. (1990). "Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas." Curr Probl Dermatol 19: 252-7.






Soprano, D. R., P. Qin, et al. (2004). "Retinoic acid receptors and cancers." Annu Rev Nutr 24: 201-21.






Su, I. J., A. L. Cheng, et al. (1993). "Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes." Br J Haematol 85(4): 826-8.






Tallman, M. S. (2004). "Acute promyelocytic leukemia as a paradigm for targeted therapy." Semin Hematol 41(2 Suppl 4): 27-32.






Thomsen, K. (1995). "Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatment." Lancet 345(8964): 1583.






Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.






Turley, J. M., S. Funakoshi, et al. (1995). "Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta." Cell Growth Differ 6(6): 655-63.






Voigt, A., P. Hartmann, et al. (2000). "Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid." Cell Adhes Commun 7(5): 423-40.






Wang, K. C., A. L. Cheng, et al. (2000). "Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions." Exp Hematol 28(12): 1441-50.






Warrell, R. P., Jr., C. J. Coonley, et al. (1983). "Isotretinoin in cutaneous T-cell lymphoma." Lancet 2(8350): 629.






Wu, Q., Z. Chen, et al. (2001). "Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression." Chin Med J (Engl) 114(9): 958-61.






Younes, A., M. Cristofanilli, et al. (2000). "Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma." Leuk Lymphoma 40(1-2): 79-85.






Zhang, C. and M. Duvic (2003). "Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma." Dermatol Ther 16(4): 322-30.

 
 
 

 

Documento Allegato

Stampa